Overview

Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ACE inhibitors alter the fibrinolytic, inflammatory, and hemodynamic response to cardiopulmonary bypass in infants and children with congenital heart disease.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors